In addition, Augustine today announced the founding of a Copenhagen, Denmark based subsidiary, Augustine Therapeutics Denmark ApS, which will serve as the company's hub for research related to ...

Juvenescence closes $76m first tranche of Series B-1 financing led by Abu Dhabi's M42 alongside strategic partnership Close of $76m Series B-1 tranche follows recent announcement of groundbreaking ...

Impaired neuromusculoskeletal function due to conditions such as stroke, osteoarthritis, cerebral palsy, Parkinson's disease, ...

Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced that the ...

Prime Medicine is eliminating 25% of its workforce in a restructuring that includes the company pivoting its prime ...

The NFL has put its coaching accelerator program designed to bolster diversity efforts on hold. It makes the NFL look weak ...

The University of Minnesota Medical School and Fairview are expanding rural physician training in the state with a new residency program. The Grand Itasca Clinic & Hospital Rural Family Medicine ...

Novo Nordisk A/S' CEO transition sparks governance concerns, but internal succession ensures stability. Click for my updated ...

Eli Lilly is further expanding its RNA medicine strategy by tapping South Korea’s Rznomics for a $1.3 billion biobucks deal ...

These drugs target some of the most pressing cancer types, including multiple myeloma, breast cancer, and bladder cancer ...